Stocks股票 / Health Care / BIIB
Biogen · Health Care
BIIB US listed · USD美股 · 美元
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases.百健公司是一家美国跨国生物技术公司，总部位于美国马萨诸塞州剑桥，专注于神经系统疾病治疗。
Large cap大盘 · $29B
Mixed profile混合特征
Health Care
S&P 500标普500
$199.95
-$6.04 · -2.93%
52w low52周低 $121high高 $220
Constructive — building a base建设性 — 正在筑底
The bottoming setup is not yet confirmed (price still below the 10-day average) and the 3-day/weekly momentum has crossed down — momentum is fading before the…筑底形态尚未确认（价格仍位于 10 日均线下方），且3 日/周线动量已向下交叉——动量在形态完成前已开始衰竭。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Engine read引擎解读 · 2026-07-21
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量（RSI 14）
48
Neutral zone中性区域
vs 50-day average相对50日均线
+0.5% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+10.4% above上方
Long trend up长期向上
Volatility波动率
100th percentile第100百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-07-3010days to go天后公布
Estimates being raised — 2 analysts预期上调 — 2 位分析师
Post-earnings drift: -7.1% (20d)财报后漂移：-7.1%（20日）
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | BIIB | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 22.70x | 28.59 | |
| P/S市销率 | 2.97x | 2.97 | |
| Earnings yield盈利收益率 | 4.41% | 2.72 | |
| FCF yield自由现金流收益率 | 6.99% | 4.00 | |
| P/FCF市值/自由现金流 | 14.31x | 22.08 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
5-yr growth5年复合增速 -6.0%
Earnings per share每股收益
5-yr growth5年复合增速 -18.7%
Free cash flow自由现金流
Net margin净利率
13.1%
FCF margin自由现金流利润率
22.3%
Balance-sheet quality财务体质 5/9
Bankruptcy risk: safe zone破产风险：安全区
Watch关注
Leverage杠杆
Current ratio流动比率2.68
Capital allocation资本配置
Stock-based comp股权薪酬$290.8M
Share count change (1y)股数变化（1年）+0.7%
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Sector / Theme行业/主题
Big Pharma theme — #3 of 46 themes「大型药企」主题 — 46 个主题中第 3 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed +10.3%空头仓位变动 +10.3%
Technical技术面
BIIB StochRSI turned up from oversoldBIIB StochRSI自超卖区上行
Options positioning期权持仓
as of last close截至上一收盘Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±2.75%
Expected weekly move预期周波动
±6.15%
Gamma flip伽玛翻转位
$169
25d risk reversal25d风险逆转
4.4%
Skew: greed偏斜：贪婪
Call and put walls are plotted on the Trade levels ladder →看涨/看跌期权墙已标注在「交易点位」阶梯上 →
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$0.7M net (0 buyers, 1 sellers)-$0.7M 净值（0 买家，1 卖家）
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Perceptive Advisors | A | exitexit | 0.0% | 2026-03-31 |
Signal history信号历史
engine events引擎事件
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP. Buyers rejected the 2026-07-14 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all买入预备。买方拒绝了 2026-07-14 的低点（摆动低点已现），但价格尚未收复 10 日均线——第一项条件达成，并非全部
Jul 16, 2026
BIIB StochRSI turned up from oversoldBIIB StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $208.92.StochRSI重回20上方 — 下行动量趋缓的最早预警。$208.92。
Jul 15, 2026
NEARING A LOW → BOTTOMING接近低点 → 筑底中
BUY SETUP买入预备
Jul 14, 2026
BIIB broke down vs the marketBIIB 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $191.95.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$191.95。
Jul 13, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 8, 2026
BIIB daily MACD crossed downBIIB 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $200.36.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$200.36。
Jul 7, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 2, 2026
BIIB took relative-strength leadershipBIIB 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $216.12.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$216.12。
Showing the last 15 of显示最近15条，共 110 signals条信号
Company profile公司档案
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases.百健公司是一家美国跨国生物技术公司，总部位于美国马萨诸塞州剑桥，专注于神经系统疾病治疗。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Above market高于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Below market低于市场
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（静态） | 22.7× | 28.6× | 66% |
| Price / Sales市销率 | 3.0× | 3.0× | 50% |
| Earnings yield盈利收益率 | 4.4% | 2.7% | 75% |
| Free-cash-flow yield自由现金流收益率 | 7.5% | 5.5% | 74% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
77/100 — stronger than most强于多数
vs market, 3 months相对大盘（3个月）
71/100 — stronger than most强于多数
vs market, 6 months相对大盘（6个月）
70/100 — stronger than most强于多数
vs market, 12 months相对大盘（12个月）
80/100 — stronger than most强于多数
Rank in sector行业内排名
#29 / 165
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -4.3% | -0.9% |
| 1 Month近1月 | +1.7% | -0.6% |
| 3 Months近3月 | +7.5% | +5.4% |
| 6 Months近6月 | +15.8% | +8.6% |
| Year to date年初至今 | +12.4% | +8.9% |
| 1 Year近1年 | +60.0% | +19.2% |
Trading information交易信息
Beta vs market贝塔
0.23
Volatility rank波动率分位
100th pctile
Short interest空头占比
3.9% of float
Market cap市值
$29B
EPS (trailing)每股收益
$8.81
Off 52-week high距52周高点
-7.7%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $13.4B | $11.0B | $10.2B | $9.8B | $9.7B | $9.9B |
| EPS每股收益 | $24.80 | $10.40 | $20.87 | $7.97 | $11.18 | $8.79 |
| Free cash flow自由现金流 | $3.8B | $3.4B | $1.1B | $1.3B | $2.7B | $2.1B |
| Gross margin毛利率 | 86.6% | 80.8% | 77.6% | 74.2% | 76.1% | 75.7% |
| Net margin净利率 | 29.8% | 14.2% | 29.9% | 11.8% | 16.9% | 13.1% |
| FCF margin自由现金流利润率 | 28.3% | 30.8% | 11.2% | 12.9% | 28.1% | 20.7% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$9.9B
Net income净利润
$1.3B
Operating cash flow经营现金流
$2.2B
Total assets总资产
$29.4B
Shares outstanding总股本
0.15B
Returns & growth回报与增长
Return on assets资产回报率
4.4%
Profit growth利润增速
-20.8%
Asset growth资产增速
+5.0%
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量：应计利润接近同业中位
- Working capital: inventory +103% vs sales +-26% — inventory building, demand risk营运资本：存货 +103% 对销售 +-26%——存货积压，需求风险
- Pricing power: gross margin −10.9pts over 6 years定价能力：毛利率 6 年下降 10.9 个百分点
- Capital discipline: investment near the peer median资本纪律：投资力度接近同业中位
- Balance sheet: Altman Z 3.12 — safe zone资产负债表：Altman Z 3.12——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
48
RSI (2-day)RSI（2日）
31
vs 20-day average相对20日均线
-2.4%
vs 50-day average相对50日均线
+0.5%
vs 200-day average相对200日均线
+10.4%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down动能向下
3-day3日线
momentum down — fresh downturn动能向下——刚刚转弱
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range state波幅状态
expanding — range opening up扩张中 — 波幅放大
Range width percentile波幅宽度分位
71/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Estimate revisions预期修正
Analysts covering覆盖分析师
2
Estimate direction预期调整方向
mostly raising多数上调
Estimate change, 90 days预期变化（90天）
+4.2%
Net upgrades, 30 days净上调（30天）
+2
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Options — full detail期权持仓 — 完整明细
Dealer positioning map做市商持仓地图
Call wall看涨期权墙
$210
Put wall看跌期权墙
$190
Gamma flip伽玛翻转位
$169
Upside magnet上方磁吸位
$210
Downside magnet下方磁吸位
$195
Net dealer gamma做市商净伽玛
+$0.0B
Distance to flip距翻转位
+15.6%
Walls and magnets are strikes with heavy open interest — price often slows or gravitates there.期权墙与磁吸位是未平仓集中的行权价 — 价格常在附近减速或被吸引。
Volatility pricing波动率定价
Implied volatility (30d)隐含波动率（30天）
0%
25-delta risk reversal25-delta风险逆转
+4.4%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Perceptive Advisors | A | Exited清仓 | 0.0% | $22M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
1
Buying vs selling买入vs卖出
0 : 1
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 14, 'holders_first': 1, 'holders_last': 0, 'holders_delta': -1, 'value_change_pct': -100.0, 'from_period': '2023-03-31', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2023-05-15', 'holders_series': [1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 1, 0, 0]}{'direction': 'distributing', 'n_quarters': 14, 'holders_first': 1, 'holders_last': 0, 'holders_delta': -1, 'value_change_pct': -100.0, 'from_period': '2023-03-31', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2023-05-15', 'holders_series': [1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 1, 0, 0]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$0.7M
Insider buyers vs sellers内部人买家vs卖家
0 : 1
Short interest空头占流通盘
3.9%
Days to cover回补天数
4.1
Short interest change空头变化
+10.3%
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。